← 返回前沿论文

γδ T 细胞介导的癌症治疗免疫应答:特别关注乳腺癌

英文原题:γδ T Cell-Mediated Immune Responses for Cancer Therapy: Special Focus on Breast Cancer.

查看英文原题

γδ T Cell-Mediated Immune Responses for Cancer Therapy: Special Focus on Breast Cancer.

PubMed 2022/01/01(内容时间) Crit Rev Immunol Q4 · IF 1.8(JCR 2025)

研究概要

三阴性乳腺癌(TNBC)是一种侵袭性强的乳腺癌(BC),缺乏雌激素和孕激素受体,且HER2/neu蛋白过表达。

中文摘要

三阴性乳腺癌(TNBC)是一种具有高度侵袭性的乳腺癌(BC),缺乏雌激素和孕激素受体,并伴有HER2/neu蛋白过表达。它比其他类型的BC更具侵袭性,常见于年轻女性。近年来,临床前和临床研究已探索使用免疫疗法治疗TNBC患者。然而,由于高水平的肿瘤突变负荷,只有一部分患者对免疫治疗有应答。肿瘤微环境(TME)细胞之间通过信号分子的双向通讯调节γδ T细胞,以支持或损害肿瘤生长。本综述强调γδ T细胞介导的免疫反应,特别关注乳腺癌。我们介绍了γδ T细胞的细胞毒性特征。我们还介绍了γδ T细胞在TME中引发促肿瘤和抗肿瘤反应的重要作用。最后,我们的综述聚焦于γδ T细胞作为乳腺癌发展中的祸害的显著特征。

展开英文摘要原文

Triple-negative breast cancer (TNBC) is a type of breast cancer (BC) with high aggressive nature, devoid of receptors for estrogen and progesterone hormones and with overexpression of the HER2/neu protein. It is more aggressive than other types of BC, common occurring in younger women. Recently, preclinical and clinical studies have investigated the use of immune therapies to treat TNBC patients. However, a subset of patients is responding to immunotherapy due to the high level of tumor mutation burden. The bidirectional communication among the tumor microenvironment (TME) cells via signal molecules modulates γδ T cells to support or impair tumor growth. This review emphasizes γδ T cell-mediated immune responses with a special focus on breast cancer. We present the cytotoxic characteristics of γδ T cells. We also present the promising role of γδ T cells in mounting pro-tumor and anti-tumor responses in the TME. Finally, our review focuses on prominent features of γδ T cells as a curse in breast cancer development.

论文信息

作者
Malla RR、Bhamidipati P
第一作者单位
Cancer Biology Laboratory, Department of Biochemistry and Bioinformatics, GIS, GITAM School of Science, GITAM (Deemed to be University), Visakhapatnam, Andhra Pradesh, 530045, India.India
通讯作者单位
Cancer Biology Laboratory, Department of Biochemistry and Bioinformatics, GITAM School of Science, GITAM (Deemed to be University), Visakhapatnam 530045, Andhra Pradesh, India.India
文献类型
综述
期刊
Critical reviews in immunology2022
原文标识
PubMed 37082947 · DOI 10.1615/CritRevImmunol.2023047363